Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Adline Chem Lab Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Adline Chem Lab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Adline Chem Lab - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    22 Apr 2025, 3:17PM Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
  • Adline Chem Lab has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 11:50AM As of March 2025, 29.61% is owned by Indian Promoters and 70.39% by Public. <p align=justify> Top five Promoters holding highest number of shares of A
  • Adline Chem Lab - Announcement under Regulation 30 (LODR)-Change in Management

    12 Apr 2025, 11:15AM Appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613) as Additional Director (Non-Executive-Non-Independent) and Mr. Nilay Jitendrabhai Vaghasi
  • Adline Chem Lab - Board Meeting Outcome for Appointment Of Additional Directors

    12 Apr 2025, 11:09AM Outcome of Board Meeting held on 12th April, 2025 for the appointment of Additional Director on the Board of Directors of the Company under Regulation
  • Adline Chem Lab - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations A

    11 Apr 2025, 4:46PM Non-applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (LODR) Regulations, 2015
  • Adline Chem Lab - Board Meeting Intimation for Appointment Of Additional Directors.

    9 Apr 2025, 5:19PM Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and
  • Adline Chem Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 4:05PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025
  • Adline Chem Lab - Integrated Filing (Financial)

    12 Feb 2025, 3:35PM Integrated Filing (Financials) for the Quarter ended 31st December, 2024.
  • Adline Chem Lab - Disclosure Regarding Submission Of Application Under Regulation 31A Of The SEBI (Listing Obligations And Di

    10 Feb 2025, 2:57PM Disclosure regarding submission of application under Regulation 31A of the SEBI (LODR) Regulations, 2015- Re-classification of Promoters.
  • Adline Chem Lab - Results For Quarter And Nine Months Ended On 31St December, 2024.

    4 Feb 2025, 5:55PM Outcome of Board Meeting held on 4th February, 2025
  • Adline Chem Lab - Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab Limited Held On 4Th Febr

    4 Feb 2025, 5:51PM Outcome of the Board Meeting held on 4th February, 2025 and has considered and approved Unaudited Financial Results for the Quarter and Nine Months en

Key fundamentals

Evaluate the intrinsic value of Adline Chem Lab Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets -0.2312 -0.2343 3.9651 4.432 6.0684
Liabilities -0.2312 -0.2343 3.9651 4.432 6.0684
Equity 5.85 5.85 5.85 5.85 5.85
Gross Profit -0.1771 -0.7966 -0.2962 -0.2305 -3.3314
Net Profit -0.1465 -4.234 0.7178 -1.2833 -3.7645
Cash From Operating Activities -0.0196 0.0138 0.2113 -0.2941 -11.3375
NPM(%) 0 0 97.44 -20.28 -57.11
Revenue 0 0 0.7366 6.3281 6.5912
Expenses 0.1771 0.7966 1.0328 6.5587 9.9227
ROE(%) 8.55 247.02 -41.87 74.87 219.62

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Adline Chem Lab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 824.20 -1.99 11.65 7.32 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 80.41 -0.74 338.42 26.66 14.01 0.62
Bharat Immunological and Biologicals Corporation Ltd 23.00 -1.41 0.00 55.36 -39.50 0.00
Astec Lifesciences Ltd 681.00 -1.58 0.00 25.14 -687.11 0.00

Company Info

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Read More

Parent Organisation

Adline Chem Lab Ltd.

Founded

06/07/1988

Managing Director

Mr.Pathak S B

NSE Symbol

FAQ

The current price of Adline Chem Lab Ltd is

The 52-week high for Adline Chem Lab Ltd is

The market capitalization of Adline Chem Lab Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Adline Chem Lab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Adline Chem Lab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Adline Chem Lab Ltd shares.

The CEO of Adline Chem Lab Ltd is Mr.Pathak S B, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT